🌍 Your knowledge portal
ciencia-natureza

Artemis II Delayed 18 Months: The Crisis Threatening America's Return to the Moon

📅 2026-04-24⏱️ 1 min read📝

Quick Summary

NASA announced on April 24, 2026 the delay of Artemis II to September 2027. A 24% budget cut and Orion technical failures are the causes.

Artemis II Delayed 18 Months: The Crisis Threatening America's Return to the Moon

NASA announced on April 24, 2026 the delay of Artemis II — which would take astronauts around the Moon for the first time since Apollo 17 — to September 2027. A 24% budget cut and three critical technical problems made a 2026 launch unviable.

Technical Causes #

Three problems: Orion European service module valve defects requiring complete replacement; Axiom Space EVA suits failing vacuum chamber pressurization tests; SLS structural integrity issues identified from Artemis I flight data analysis.

Budget Crisis Behind the Problems #

The Trump administration cut NASA's budget by 24% for FY2026, with 38% cuts in the human exploration division. Compressed test schedules allowed problems to emerge later — already critical.

What's at Stake: The Race with China #

China targets a crewed lunar landing by 2030. With Artemis II in 2027 and Artemis III in 2028-2029, the American margin is dangerously narrow.

Impact Table #

Milestone Original Date New Date
Artemis II (crewed flyby) 2026 Sep 2027
Artemis III (lunar landing) 2027 2028-2029
China lunar landing (goal) 2030
NASA budget cut 2026 -24%

Sources #

  • NASA — Artemis II Schedule Update April 2026
  • Space News — Artemis budget crisis
  • Ars Technica — Artemis II delay causes

📢 Gostou deste artigo?

Compartilhe com seus amigos e nos conte o que você achou nos comentários!

Receba novidades!

Cadastre seu email e receba as melhores curiosidades toda semana.

Sem spam. Cancele quando quiser.

💬 Comentários (0)

Seja o primeiro a comentar! 👋

📚Read Also

FDA Approves Otarmeni: The Gene Therapy That Gives Hearing to Children Born Deafciencia-natureza

FDA Approves Otarmeni: The Gene Therapy That Gives Hearing to Children Born Deaf

Regeneron's Otarmeni became the first FDA-approved gene therapy for hereditary hearing loss caused by OTOF gene mutations in April 2026, restoring hearing in children who were profoundly deaf from bir

⏱️5 minLer mais →
Toxic Leak in West Virginia: Hydrogen Sulfide Kills 2, Hospitalizes 19 at Silver Refineryciencia-natureza

Toxic Leak in West Virginia: Hydrogen Sulfide Kills 2, Hospitalizes 19 at Silver Refinery

On April 22, 2026, the accidental mixing of nitric acid and M2000A at the Ames Goldsmith silver refinery in Institute, West Virginia, released toxic hydrogen sulfide gas, killing 2 workers and sending

⏱️9 minLer mais →
ANVISA Approves Polylaminin: Brazil's Breakthrough Treatment for Spinal Cord Injuryciencia-natureza

ANVISA Approves Polylaminin: Brazil's Breakthrough Treatment for Spinal Cord Injury

ANVISA granted landmark approval for polylaminin-based therapy for spinal cord injury in April 2026, offering the first disease-modifying treatment for paralysis patients in Brazil.

⏱️2 minLer mais →
Curiosity Detects Unprecedented Organic Compounds on Mars — Including a DNA Precursorciencia-natureza

Curiosity Detects Unprecedented Organic Compounds on Mars — Including a DNA Precursor

NASA's Curiosity rover detected organic molecules in Mars's Gale Crater, including a nitrogen compound similar to DNA precursors. The discovery reignites debate about past life on the Red Planet.

⏱️4 minLer mais →
Georgia and Florida on Fire: The Southeast's Worst Wildfire Crisis in Decadesciencia-natureza

Georgia and Florida on Fire: The Southeast's Worst Wildfire Crisis in Decades

Driven by severe drought, low humidity, and high winds, fast-moving wildfires ripped through Georgia and Florida on April 21–23, 2026, destroying more than 50 homes and forcing thousands of residents

⏱️9 minLer mais →
CAR-T Therapy Cures Stiff Person Syndrome: A Medical Breakthrough in 2026ciencia-natureza

CAR-T Therapy Cures Stiff Person Syndrome: A Medical Breakthrough in 2026

Kyverna Therapeutics' miv-cel CAR-T therapy successfully treated Stiff Person Syndrome in a Phase 2 trial: 81% of patients improved mobility and 67% abandoned wheelchairs in 16 weeks.

⏱️6 minLer mais →